STAT3 and neoplasm: Dysregulation and constitutive activation of STAT3 stimulates cancer cell growth and contributes to tumor development and progression by upregulation of STAT3 target genes including Bcl-2, c-myc, cyclin D1 and VEGF, which can enhance cell survival, proliferation and promote angiogenesis [15], [16], [17].